{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:02:28Z","timestamp":1790704948983,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T00:00:00Z","timestamp":1393286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000199","name":"USDA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000840","name":"ARS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000180","name":"U.S. Department of Homeland Security","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.vaccine.2014.02.066","type":"journal-article","created":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T06:45:28Z","timestamp":1394865928000},"page":"2337-2344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Development of a Rift Valley fever virus viremia challenge model in sheep and goats"],"prefix":"10.1016","volume":"32","author":[{"given":"Hana M.","family":"Weingartl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrna","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Nfon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7877-9224","authenticated-orcid":false,"given":"William C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.02.066_bib0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley fever virus (Bunayviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"Pepin","year":"2010","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0010","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2174\/156652405774962263","article-title":"Rift Valley fever virus","volume":"5","author":"Flick","year":"2005","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0015","first-page":"261","article-title":"The use of veterinary vaccines for prevention and control of Rift Valley fever: memorandum from a WHO\/FAO meeting","volume":"61","year":"1983","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0020","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1128\/JVI.02641-10","article-title":"Rift Valley fever: recent insights into pathogenesis and prevention","volume":"85","author":"Boshra","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0025","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.vaccine.2012.03.027","article-title":"Efficacy of three candidate Rift Valley fever vaccines in sheep","volume":"30","author":"Kortekaas","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0030","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1128\/JVI.06046-11","article-title":"Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep","volume":"85","author":"Bird","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0035","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley fever Clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0040","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"Morill","year":"1997","journal-title":"AJVR"},{"issue":"2","key":"10.1016\/j.vaccine.2014.02.066_bib0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jviromet.2011.11.025","article-title":"Development and evaluation of one-step rRT-PCR and immunohisto-chemical methods for detection of Rift Valley fever virus in biosafety level 2 diagnostic laboratories","volume":"179","author":"Drolet","year":"2012","journal-title":"J Virol Methods"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2014.02.066_bib0050","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/vbz.2009.0205","article-title":"Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates","volume":"10","author":"Busquets","year":"2010","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0034-5288(18)32908-4","article-title":"Clinical, virological and serological response of the West African dwarf sheep to experimental infection with different strains of Rift Valley fever virus","volume":"26","author":"Tomori","year":"1979","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/vr.109.17.383","article-title":"Abortion in vaccinated sheep and cattle after challenge with Rift Valley fever virus","volume":"109","author":"Yedloutschnig","year":"1981","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0065","first-page":"53","article-title":"Rift Valley fever infection in sheep by contact exposure","volume":"3","author":"Yedloutschnig","year":"1981","journal-title":"Contrib Epidemiol Biostat"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.19182\/remvt.9548","article-title":"Experimental infection of three Nigerian breeds of sheep with the Zinga strain of the Rift Valley fever virus","volume":"49","author":"Olaleye","year":"1996","journal-title":"Rev Elev Med Vet Pays Trop"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0075","first-page":"1231","article-title":"Experimental Rift Valley fever in lambs and sheep","volume":"23","author":"Easterday","year":"1962","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0080","first-page":"1224","article-title":"Experimental Rift Valley fever in calves, goats, and pigs","volume":"23","author":"Easterday","year":"1962","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0085","first-page":"273","article-title":"Studies on goats experimentally infected with R.V.F. virus","volume":"LIII","author":"Iman","year":"1978","journal-title":"J Egypt Public Health Assoc"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0034-5288(18)33591-4","article-title":"Experimental Rift Valley fever in West African Dwarf sheep","volume":"18","author":"Fagbami","year":"1975","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0095","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.virusres.2011.10.023","article-title":"Animal models of Rift Valley fever virus infection","volume":"163","author":"Ross","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-6-94","article-title":"Pathological studies on postvaccinal reactions of Rift Valley fever in goats","volume":"6","author":"Kamal","year":"2009","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0105","doi-asserted-by":"crossref","first-page":"e1623","DOI":"10.1371\/journal.pntd.0001623","article-title":"Innate immune response to Rift Valley fever virus in goats","volume":"6","author":"Nfon","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0110","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1099\/0022-1317-69-4-817","article-title":"Characterization of attenuated strains of Rift Valley fever virus","volume":"69","author":"Rossi","year":"1988","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0115","doi-asserted-by":"crossref","first-page":"e87385","DOI":"10.1371\/journal.pone.0087385","article-title":"Rift Valley fever virus incorporates the 78kDa glycoprotein into virions matured in mosquito C6\/36 cells","volume":"9","author":"Weingartl","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2013.12.064","article-title":"Efficacy of recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep","author":"Weingartl","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0125","doi-asserted-by":"crossref","first-page":"e1156","DOI":"10.1371\/journal.pntd.0001156","article-title":"Host alternation is necessary to maintain the genome stability of Rift Valley fever virus","volume":"5","author":"Moutailler","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.chom.2011.06.007","article-title":"DC-SIGN as a receptor for phleboviruses","volume":"10","author":"Lozach","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0135","doi-asserted-by":"crossref","first-page":"12022","DOI":"10.1128\/JVI.77.22.12022-12032.2003","article-title":"DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses","volume":"77","author":"Klimstra","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.01590-06","article-title":"Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses","volume":"81","author":"Shabman","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0145","doi-asserted-by":"crossref","first-page":"13640","DOI":"10.1128\/JVI.00857-07","article-title":"Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells","volume":"81","author":"Silva","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.02.066_bib0150","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/JVI.06190-11","article-title":"Development of a novel nonhuman primate model for Rift Valley fever","volume":"86","author":"Smith","year":"2012","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14002734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14002734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T01:08:56Z","timestamp":1716599336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14002734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":30,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0264410X14002734"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a Rift Valley fever virus viremia challenge model in sheep and goats","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}